Your session is about to expire
← Back to Search
Telehealth for Contraception
Study Summary
This trial explores using a certain pill to help people avoid pregnancy over the next year.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I would not consider terminating a pregnancy if I became pregnant in the next year.I would choose to end a pregnancy within the next year and prefer not to have an in-office procedure.I am not pregnant and do not plan to become pregnant in the next year.I don't have bleeding disorders, long-term steroid use, porphyria, or allergies to specific medications.I am between 18 and 40 years old.I am between 18 and 40 years old.
- Group 1: Telehealth Visit
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who can lawfully engage in this clinical investigation?
"Those who hope to be accepted into this trial must have a viable uterus and fall within the 18-40 year age group. This clinical study is aiming for an enrolment of 200 individuals."
Is the recruitment for this research restricted to individuals aged 30 and above?
"For this particular trial, the age range of enrollees is set between 18 and 40. Other trials are available for younger participants (age ≤18) or older individuals (≥65)."
How precarious is a Telehealth Visit for patients?
"We have assigned Telehealth Visit a safety rating of 3 on our 1-3 scale, as this procedure has been authorised after successful completion of Phase 4 trials."
Is there still room for participants in this research endeavor?
"According to clinicaltrials.gov, the recruitment period for this trial has concluded as it was last modified on April 28th 2023. Nevertheless, there are still 145 other trials actively signing up participants at present."
Share this study with friends
Copy Link
Messenger